Simple chiral chain dienes as ligands for Rh(I)-catalyzed conjugated additions.Org Lett. 2009 Oct 15; 11(20):4744-7.OL
Abstract
This paper describes that a simple and readily available chain diene (3R,4R)-hexa-1,5-diene-3,4-diol (L1) was successfully utilized as a novel steering ligand for Rh(I)-catalyzed asymmetric conjugated additions. Encouraging yields and ee's have been achieved, which may provide a new and practical direction for designing chiral diene ligands in the future.
Links
Pub Type(s)
Journal Article
Language
eng
PubMed ID
19761192
Citation
Hu, Xichao, et al. "Simple Chiral Chain Dienes as Ligands for Rh(I)-catalyzed Conjugated Additions." Organic Letters, vol. 11, no. 20, 2009, pp. 4744-7.
Hu X, Zhuang M, Cao Z, et al. Simple chiral chain dienes as ligands for Rh(I)-catalyzed conjugated additions. Org Lett. 2009;11(20):4744-7.
Hu, X., Zhuang, M., Cao, Z., & Du, H. (2009). Simple chiral chain dienes as ligands for Rh(I)-catalyzed conjugated additions. Organic Letters, 11(20), 4744-7. https://doi.org/10.1021/ol901949n
Hu X, et al. Simple Chiral Chain Dienes as Ligands for Rh(I)-catalyzed Conjugated Additions. Org Lett. 2009 Oct 15;11(20):4744-7. PubMed PMID: 19761192.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Simple chiral chain dienes as ligands for Rh(I)-catalyzed conjugated additions.
AU - Hu,Xichao,
AU - Zhuang,Minyang,
AU - Cao,Ziping,
AU - Du,Haifeng,
PY - 2009/9/19/entrez
PY - 2009/9/19/pubmed
PY - 2009/9/19/medline
SP - 4744
EP - 7
JF - Organic letters
JO - Org Lett
VL - 11
IS - 20
N2 - This paper describes that a simple and readily available chain diene (3R,4R)-hexa-1,5-diene-3,4-diol (L1) was successfully utilized as a novel steering ligand for Rh(I)-catalyzed asymmetric conjugated additions. Encouraging yields and ee's have been achieved, which may provide a new and practical direction for designing chiral diene ligands in the future.
SN - 1523-7052
UR - https://www.unboundmedicine.com/medline/citation/19761192/Simple_chiral_chain_dienes_as_ligands_for_Rh_I__catalyzed_conjugated_additions_
L2 - https://doi.org/10.1021/ol901949n
DB - PRIME
DP - Unbound Medicine
ER -